Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture

This is the authors' abstract. We don't add key points for this paper.

An annual infusion of zoledronic acid within 90 days after repair of a low-trauma hip fracture was associated with a reduction in the rate of new clinical fractures and with improved survival. (ClinicalTrials.gov number, NCT00046254 [ClinicalTrials.gov].).